Critical care of the pediatric hematopoietic stem cell recipient in 2005

Pediatric Transplantation

Volumn 9, Issue SUPPL. 7, 2005, Pages 12-24

  Sullivan, Kevin J ^a,b   Goodwin, Salvatore R ^a   Sandler, Eric ^a   Joyce, Michael ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

Continuous venovenous hemofiltration; Hematopoietic stem cell transplantation; Multiple organ dysfunction syndrome; Multiple organ system failure; Pediatric; Respiratory failure; Septic shock

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTITHROMBIN III; BUDESONIDE; CASPOFUNGIN; CIDOFOVIR; DEFIBROTIDE; ETANERCEPT; FOSCARNET; GANCICLOVIR; INFLIXIMAB; LOW MOLECULAR WEIGHT HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; RIBAVIRIN; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE;

BACTERIAL INFECTION; BRONCHOPNEUMONIA; CHILDHOOD CANCER; CLINICAL TRIAL; CONFERENCE PAPER; GENOMICS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INBORN ERROR OF METABOLISM; INTENSIVE CARE; INTENSIVE CARE UNIT; LUNG EDEMA; MEDICAL PRACTICE; MUCOSA INFLAMMATION; MYCOSIS; NEUTROPENIA; OBSTRUCTIVE AIRWAY DISEASE; PNEUMONIA; PROGNOSIS; PROTOZOAL INFECTION; PUBLIC HEALTH SERVICE; RESPIRATORY FAILURE; TREATMENT OUTCOME; VIRUS INFECTION;

CHILD; CRITICAL CARE; GENOMICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY FAILURE; MEDICAL ONCOLOGY; MULTIPLE ORGAN FAILURE; RESPIRATORY INSUFFICIENCY; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 28344434227     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00448.x     Document Type: Conference Paper

References (62)

1. RUBENFELD GD, CRAWFORD SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence based guidelines. Ann Intern Med 1996: 125: 625-633.
2. POLLACK MM, RUTTIMANN UE, GETSON PR. Pediatric risk of mortality (PRISM) score. Crit Care Med 1988: 16: 1110-1116.
3. SHANN F, PEARSON G, SLATER A, WILKINSON K. Paediatric index of mortality (PIM): a mortality prediction model for children in intensive care. Intensive Care Med 1997: 23: 201-207.
4. POLLACK MM, PATEL KM, RUTTIMANN UE. PRISM III: an updated pediatric risk of mortality score. Crit Care Med 1996: 24: 743-752.
5. LETEURTRE S, MARTINOT A, DUHAMEL A, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 2003: 362: 192-197.
6. SLATER A, SHANN F, ANZICS Paediatric Study Group. The suitability of the pediatric index of mortality (PIM), PIM II, the pediatric risk of mortality (PRISM), and PRISM III for monitoring the quality of pediatric intensive care in Australia and New Zealand. Pediatr Crit Care Med 2004: 5: 447-454.
7. VAN VEEN A, KARSTENS A, VAN DER HOEK ACJ, TIBBOEL D, HAHLEN K, VAN DER VOORT E. The prognosis of oncologic patients in the pediatric intensive care unit. Intensive Care Med 1996: 22: 237-241.
8. SCHNEIDER DT, LEMBURG P, SPROCK I, GOBEL U, NURNBERGER W. Introduction of the pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children. Bone Marrow Transplant 2000: 25: 1079-1086.
9. SCHNEIDER DT, CHO J, LAWS HJ, DILLOO D, GOBEL U, NURNBERGER W. Serial evaluation of the oncological pediatric risk of mortality (O-PRISM) score following allogeneic bone marrow transplantation in children. Bone Marrow Transplant 2002: 29: 383-389.
10. COBB JP, LARAMIE JM, STORMO GD, et al. Sepsis gene expression profiling: murine splenic compared with hepatic responses determined by using complementary DNA microarrays. Crit Care Med 2002: 30: 2711-2721.
11. DASU MRK, COBB JP, LARAMIE JM, CHUNG TP, SPIES M, BARROW RE. Gene expression profiles of livers from thermally injured rats. Gene 2004: 327: 51-60.
12. TODD K, WILEY F, LANDAW E, et al. Survival outcome among 54 intubated pediatric bone marrow transplant patients. Crit Care Med 1994: 22: 171-176.
13. BOJKO T, NOTTERMAN DA, GREENWALD BM, et al. Acute hypoxemic respiratory failure in children following bone marrow transplantation: an outcome and pathologic study. Crit Care Med 1995: 23: 755-759.
14. NICHOLS DG, WALKER LK, WINGARD JR, et al. Predictors of acute respiratory failure after bone marrow transplantation in children. Crit Care Med 1994: 22: 1485-1491.
15. HAYES C, LUSH RJ, CORNISH JM, et al. The outcome of children requiring admission to an intensive care unit following bone marrow transplantation. Br J Haematol 1998: 102: 666-670.
16. WARWICK AB, MERTENS AC, OU SHU X, et al. Outcomes following mechanical ventilation in children undergoing bone marrow transplantation. Bone Marrow Transplant 1998: 22: 787-794.
17. ROSSI R, SHEMIE S, CALDERWOOD S. Prognosis of pediatric bone marrow transplant recipients requiring mechanical ventilation. Crit Care Med 1999: 27: 1181-1186.
18. SCHMIDT J. American Academy of Pediatrics National Conference and Exhibition. San Francisco, California, 2004.
19. AMATO MB, BARBAS CS, MEDEIROS DM, et al. Effect of a protective- ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998: 338: 347-354.
20. TAKEUCHI M, GODDON S, DOLHNIKOFF M, et al. Set positive end-expiratory pressure during protective ventilation affects lung injury. Anesthesiology 2002: 97: 682-692.
21. ARNOLD JH, HANSON JH, TORO-FIGUERO LO, GUTIERREZ J, BERENS RJ, ANGLIN DL. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994: 22: 1530-1539.
22. MEHTA S, LAPINSKY SE, HALLETT DC, et al. Prospective trial of high-frequency oscillation in adults with acute respiratory distress syndrome. Crit Care Med 2001: 29: 1360-1369.
23. HAGEN S, CRAIG DM, MARTIN PL, et al. Mechanically ventilated pediatric stem cell transplant recipients: effect of cord blood transplant and organ dysfunction on outcome. Pediatr Crit Care Med 2003: 4: 206-213.
24. WILSON DF, THOMAS NJ, MARKOVITZ BP, et al. Effect of exogenous surfactant (Calfactant) in pediatric acute lung injury: a randomized control trial. JAMA 2005: 293: 470-476.
25. AZOULAY E, ALBERTI C, BORNSTAIN C, et al. Improved survival in cancer patients requiring mechanical ventilatory support. Crit Care Med 2001: 29: 519-525.
26. HILBERT G, GRUSON D, VARGAS F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001: 344: 481-487.
27. EFRATI O, MODAN-MOSES D, BARAK A, et al. Long-term non-invasive positive pressure ventilation among cystic fibrosis patients awaiting lung transplantation. Isr Med Assoc J 2004: 6: 527-530.
28. UEDA T, TABUENA R, MATSUMOTO H, et al. Successful weaning using noninvasive positive pressure ventilation in a patient with status asthmaticus. Intern Med 2004: 43: 1060-1062.
29. REDDY VG, NAIR MP, BATACLAN F. Role of non-invasive ventilation in difficult-to-wean children with acute neuromuscular disease. Singapore Med J 2004: 45: 232-234.
30. RASCHE K, HADER C, LEIDAG M, DUCHNA HW, ORTH M. Noninvasive ventilation in chronic obstructive pulmonary disease. J Physiol Pharmacol 2004: 55(Suppl. 3): 115-119.
31. DiCARLO JV, ALEXANDER SR, AGARWAL R, SCHIFFMAN J. Continuous venovenous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol 2003: 25: 801-805.
32. HENEY D, LEWIS IJ, LOCKWOOD L, COHEN AT, BAILEY CC. The intensive care unit in paediatric oncology. Arch Dis Child 1992: 67: 294-298.
33. ABRAHAM RB, TOREN A, ONO N, et al. Predictors of outcome in the pediatric intensive care unit of children with malignancies. J Pediatr Hematol Oncol 2002: 24: 23-26.
34. FISER RT, WEST NK, BUSH AJ, SILLOS EM, SCHMIDT JE, TAMBURRO RF. Outcome of severe sepsis in pediatric oncology patients. Pediatr Crit Care Med 2005: 6: 531-536.
35. RIVERS E, NGUYEN B, HAVSTAD S, et al. Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001: 3435: 1368-1377.
36. BERNARD GR, VINCENT JL, EATERRE PF, et al. Efficacy and safety for recombinant human activated protein C for severe sepsis. N Engl J Med 2001: 344: 699-709.
37. BERNARD GR, MARGOLIS BD, SHANIES HM, et al. Extended evaluation of recombinant human activated protein C United States trial (ENHANCE US): a single-arm, phase 3B, multi-center study of drotrecogin alfa (activated) in severe sepsis. Chest 2004: 125: 2206-2216.
38. LEFERING R, NEUGEBAUER EA. Steroid controversy in septic shock: a meta-analysis. Crit Care Med 1995: 23: 1294-1303.
39. BOLLAERT PE, CHARPENTIER C, LEVY B, DEBOUVERIE M, AUDIBERT G, LARCAN A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998: 26: 645-650.
40. ANNANE D, SEBILLE V, CHARPENTIER C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002: 288: 862-871.
41. ANNANE D, BELLISSANT E, BOLLAERT PE, BRIEGEL J, KEH D, KUPFER Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 2004: 329: 480.
42. BEISHUIZEN A, THIJS LG, VERMES I. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multi-trauma. Intensive Care Med 2001: 27: 1584-1591.
43. VAN DEN BERGHE G, WOUTERS P, WEEKERS F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001: 345: 1359-1367.
44. GOLDSTEIN SL, CURRIER H, GRAF JM, COSIO CC, BREWER ED, SACHDEVA R. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001: 107: 1309-1312.
45. POLAND JA, FORTENBERRY JD, WARSHAW BL, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med 2004: 32: 1771-1776.
46. MICHAEL M, KUEHNLE I, GOLDSTEIN SL. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol 2004: 19: 91-95.
47. TOMASKE M, BOSK A, EYRICH M, BADER P, NIETHAMMER D. Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation. Br J Haematol 2003: 121: 886-891.
48. HEYING R, SCHNEIDER DT, KORHOLZ D, STANNIGEL H, LEMBURG P, GOBEL U. Efficacy and outcome of intensive care in pediatric oncologic patients. Crit Care Med 2001: 29: 2276-2280.
49. KIST-VAN HOLTHE JE, GOEDVOLK CA, BRAND R, et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002: 17: 1032-1037.
50. LANE PH, MAUER SM, BLAZAR BR, RAMSAY NKC, KASHTAN CE. Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 1994: 13: 613-617.
51. BOTTOMS G, FESSLER J, MURPHEY E, et al. Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration. Shock 1996: 5: 149-154.
52. VEENMAN JN, DUJARDINT CL, HOEAK A, GROOTENDORST A, KLEIN WR, RUTTER VP. High volume continuous veno-venous hemofiltration in an equine endotoxaemic shock model. Equine Vet J 2002: 34: 516-522.
53. KELLUM JA, JOHNSON JP, KRAMER D. PALEVSKY P, BRADY JJ, PINSKY MR. Diffusive versus convective therapy: effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998: 26: 1995-2000.
54. COLE L, BELLOMO R, JOURNOIS D, DAVENPORT P, BALDWIN I, TIPPING P. High volume haemofiltration in human septic shock. Intensive Care Med 2001: 27: 978-986.
55. BELLOMO R, TIPPING P, BOYCE N. Interleukin-6 and interleulin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Ren Fail 1995: 17: 457-466.
56. COLE L, BELLOMO R, HART G, et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002: 30: 100-106.
57. YEKEBAS EF. TREEDE H, KNOEFEL WT, BLOECHLE C, FINK E, IZBICKI JR. Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg 1999: 229: 514-522.
58. XIE H, JI D, GONG D, et al. Continuous veno-venous hemofiltration in treatment of acute necrotizing pancreatitis. Chin Med J 2003: 116: 549-553.
59. PEROUANSKY M, OPPENHEIM A, SPRUNG CL, EIDELMAN LA, PIZOV R. Effect of haemofiltration on pathological fibrinolysis due to severe sepsis: a case report. Resuscitation 1999: 40: 53-56.
60. CHEUK DK, HA SY, LEE SL, CHAN GCF, TSOI NS, LAU YL. Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant. Hematol Oncol 2004: 22: 1-9.
61. AFESSA B, LITZOW MR, TEFFERI A. Bronchiolitis obliterans and other non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001: 28: 425-434.
62. CRAWFORD SW. Critical Care and Respiratory Failure. In: THOMAS ED, BLUME KG, FORMAN SJ, eds. Hematopoietic Cell Transplantation. 2nd edn. Malden, Mass.: Blackwell Science Inc.. p. 713.